291
Views
6
CrossRef citations to date
0
Altmetric
Review

Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects

, , &
Pages 1035-1045 | Received 26 Apr 2016, Accepted 01 Jun 2016, Published online: 17 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stefano de Biase, Gaia Pellitteri, Gian Luigi Gigli & Mariarosaria Valente. (2019) Advancing synthetic therapies for the treatment of restless legs syndrome. Expert Opinion on Pharmacotherapy 20:16, pages 1971-1980.
Read now

Articles from other publishers (5)

Gian L. Gigli, Stefano de Biase, Gaia Pellitteri, Sara Pez, Riccardo Garbo, Yan Tereshko & Mariarosaria Valente. 2023. Encyclopedia of Sleep and Circadian Rhythms. Encyclopedia of Sleep and Circadian Rhythms 743 756 .
Usman Riaz & Jacob Gohari. (2021) Emergence of Restless Leg Syndrome Secondary to Psychotropic Medications. Psychiatric Annals 51:4, pages 202-204.
Crossref
nora marcela mendoza serna, Alberto Fernández Delgado & Maria Alejandra Herrera Mondragón. (2021) Aparición tardía de síndrome de piernas inquietas como síntoma de abstinencia a la metadona en pacientes oncológicos: reporte de dos casos. Revista de la Sociedad Española del Dolor 28.
Crossref
Tian-tian Ma, Zhikai Yang, Sainan Zhu, Jing-hong Zhao, Yi Li, Fu-yun Sun, Nan Zhao, Zu-ying Xiong, Zi-bo Xiong & Jie Dong. (2020) Pramipexole in peritoneal dialysis patients with restless legs syndrome (RLS): a protocol for a multicentre double-blind randomised controlled trial. BMJ Open 10:2, pages e033815.
Crossref
Michael H. Silber, Philip M. Becker, Mark J. Buchfuhrer, Christopher J. Earley, William G. Ondo, Arthur S. Walters & John W. Winkelman. (2018) The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome. Mayo Clinic Proceedings 93:1, pages 59-67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.